Kim Seok Hyun, Kim Ga Yun, Oh Ji Soo, Lee Soo Yong
Division of Cardiology, Department of Internal Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Korean J Transplant. 2021 Dec 31;35(4):257-261. doi: 10.4285/kjt.21.0029.
Heart disease is often accompanied by lung disease as they share the same risk factors. Heart or lung transplantation is regarded as a definitive treatment for the end-stage disease of each, while the expected median survival for lung transplantation is far shorter than heart transplantation. We present a case of refractory heart failure along with severe obstructive and restrictive lung disease that showed dramatic improvement in pulmonary function after single heart transplantation.
心脏病常伴有肺病,因为它们有相同的风险因素。心脏或肺移植被视为各自终末期疾病的确定性治疗方法,而肺移植的预期中位生存期远短于心脏移植。我们报告一例难治性心力衰竭合并严重阻塞性和限制性肺病的病例,该病例在单心脏移植后肺功能有显著改善。